Murine models of RA have demonstrated that AHR activation with TCDD or FICZ can contribute to RA disease progression, disease severity, bone destruction, osteoclasts differentiation, and increased numbers of IL17-expressing cells in the inflamed joints [11]. The gene discussed is IL17A; the disease is rheumatoid arthritis.